Flanders Vaccine Pitch & Match Session

13 Jun 2024 | Park Inn by Radisson Leuven

Thursday, 13 June 2024 | 14:30 - 15:15

Pitch session

Format:In-person
23 participants

The following selected pitch presenters will share their innovative project results, technologies, products or services contributing to the development of next generation vaccines and immunotherapy:

  • Presenting LVT-001, a unique mucosal vaccine up to stop viral infection contagiousness – Serge Pampfer, Lovaltech

  • Therapeutic vaccination with auto-antigen mRNA loaded Tol-cLNP cures murine model of multiple sclerosis – Paulien Baeten, Hasselt University & etherna BV

  • XVR013m, a variant-proof antibody with exceptional potency to prevent and treat COVID-19 – Viki Bockstal, ExeVir

  • Innovative Antigen Design: Integrating AI and cryoEM for Next-Generation Vaccines - Moises Maestro, PUXANO

  • Intratumoral administration of autologous myeloid dendritic cells with the immunologic adjuvant AS01B in refractory advanced melanoma: a phase I clinical trial – Manon Vounckx, VUB

  • P95: From Epidemiology Consulting to Comprehensive Vaccine CRO – Kaatje Bollaerts, P95

  • High-sensitive immunopeptidomics uncovers actionable antigens paving the way for optimized vaccine development – Pieter-Paul Strybol, ImmuneSpec

  • New class of cancer vaccine based on an off-the-shelf Antigen Presenting Cell line (PDC*line) – Eric Halioua, PDC*line Pharma

8 speakers